Company Overview and News

17
Agilent (A) Gets FDA Approval for Cervical Cancer Test Assay

2018-06-14 zacks
Agilent Technologies (A - Free Report) recently received approval from the FDA for a cervical cancer diagnostic assay, named PD-L1 IHC 22C3 pharmDx, for expanded use.
EXPE GRPN A PETS

111
Amazon's Two-Hour Whole Foods Delivery Expands to New Cities

2018-06-13 zacks
Amazon.com Inc. (AMZN - Free Report) continues to expand its two-hour Whole Food delivery Service. Baltimore, Boston, Philadelphia and Richmond are the latest additions to the list of cities receiving this service.
DLTR EXPE GRPN AMZN DG LMHA PETS LMHB LM

124
Meituan is said to plan a US$6 bil IPO filing this month

2018-06-13 theedgemarkets
(June 13): China’s restaurant review and delivery giant Meituan Dianping plans to file for an initial public offering of about US$6 billion in Hong Kong as soon as this month, according to people familiar with the matter, the city’s second multibillion-dollar public listing by a tech startup this year.
BABA GRPN BKNG 0700 BIDU

17
Amazon (AMZN) Offers Whole Foods Discounts to 10 More States

2018-06-12 zacks
Amazon AMZN recently expanded the availability of Whole Foods discount across 10 new U.S. states to its Prime members.
WFM EXPE GRPN TRI PETS

54
Fitbit Ace Launch for Children Pushes Stock Up More Than 14%

2018-06-12 zacks
Fitbit Inc.’s (FIT - Free Report) growth has been undeniably hampered by popularity of smartwatches in the fitness wearable category, increasing competition and lack of upgrades among existing users.
EXPE GRPN FIT TRI PETS

187
GRPN / Groupon, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-06-11 fintel.io
Groupon, Inc. (NASDAQ:GRPN) has 213 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 393,006,620 shares. Largest shareholders include FMR LLC / Fidelity, Vanguard Group Inc, Alibaba Group Holding Ltd, BlackRock Inc., Jericho Capital Asset Management L.P., First Trust Advisors Lp, Pictet Asset Management Ltd, BlackRock Institutional Trust Company, N.
GRPN BABA BLK VBLT VBLTF STML ALDR

9
GRPN / Groupon, Inc. / FMR LLC / Fidelity - null (Passive Investment)

2018-06-11 sec.gov
SCHEDULE 13G Amendment No. 5 GROUPON INC COMMON STOCK Cusip #399473107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #399473107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 5,687,281 Item 6: 0 Item 7: 34,942,278 Item 8: 0 Item 9: 34,942,278 Item 11: 6.188% Item 12: HC Cusip #399473107 Item 1: Reporting Person - Abigail P.
GRPN

10
GRPN / Groupon, Inc. / FMR LLC / Fidelity - null (Passive Investment)

2018-06-11 sec.gov
SCHEDULE 13G Amendment No. 5 GROUPON INC COMMON STOCK Cusip #399473107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #399473107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 5,687,281 Item 6: 0 Item 7: 34,942,278 Item 8: 0 Item 9: 34,942,278 Item 11: 6.188% Item 12: HC Cusip #399473107 Item 1: Reporting Person - Abigail P.
GRPN

15
Trimble Prices $900M Senior Notes, Gets Moody's Baa3 Rating

2018-06-11 zacks
Trimble Inc. (TRMB - Free Report) recently announced an offering of senior notes aggregating $900 million. These notes have been issued in two tranches of different amounts with varying coupon rates and maturities.
XEL EXPE GRPN HSC PETS

172
Why Is Groupon (GRPN) Down 5.7% Since Its Last Earnings Report?

2018-06-08 zacks
It has been about a month since the last earnings report for Groupon, Inc. (GRPN - Free Report) . Shares have lost about 5.7% in that time frame.
GRPN MU CCV.CL CCV CMCSA CCZ LB CMCSK

212
Amazon (AMZN) Unveils New Alexa-Powered Device Fire TV Cube

2018-06-08 zacks
Amazon.com Inc. (AMZN - Free Report) has already witnessed huge success with its video streaming devices, which were rolled out four years ago.
EXPE GRPN AMZN MU PETS LB

115
Alibaba's (BABA) AI Program to Aid Its Growth in Agriculture

2018-06-07 zacks
Alibaba Group Holding Limited’s (BABA - Free Report) cloud computing arm has unveiled ET Agricultural Brain, a program based on the power of artificial intelligence (“AI”) to improve the agricultural productivity of China. Notably, this move is in sync with the company’s focus on reinforcing its presence in the cloud market. The program will aid the companies involved in the farming of fruits, vegetables and livestock, especially pigs by providing efficient and technically advanced ways of farm management.
JD BABA GRPN

74
International Opportunities Abound for Leading Internet Retailers

2018-06-06 zacks
Retail ecommerce remains a fairly small part of total retail right now, but because it is a fast-growing part, it is increasingly accounting for a larger share. Just a year ago, we were looking at a mid-single digit share, but this year, eMarketer thinks that share will be a tenth of global retail sales.
TRIP MOMO ELLI SABR QNST GRPN EXPE ECOM DBX GLOB PETS BIDU TTD ETSY

84
Amazon and 4 Other Stocks to Buy in E-commerce Space

2018-06-06 zacks
Amazon (AMZN - Free Report) has been dominating the e-commerce domain with its aggressive retail strategy. Expanding seller base, distribution strength, strategic acquisitions and partnerships have helped the company sustain its market share despite intensifying competition. The company is well poised to leverage e-commerce sector’s growth potential. According to data from Statista, revenues in this sector are expected to hit $1.
WFM EXPE GRPN AIG.WS AVF TRIP PETS AIG 8685

175
Alibaba's Arm Partners With SAP to Expand Cloud Offerings

2018-06-06 zacks
Alibaba Group Holding Limited’s (BABA - Free Report) cloud computing arm, Alibaba Cloud recently expanded its partnership with an enterprise application software company, SAP SE (SAP). The partnership is aimed at creating a seamless transition to cloud infrastructure for enterprises, and better management of scalable workloads and critical applications.
LFUS BABA GRPN SAP AMZN SAPGF

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

4h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to GRPN / Groupon, Inc. on message board site Silicon Investor.

Groupon, Inc. MYRY GRPN Killer?
CUSIP: 399473107